Lufax Holding Ltd ADR (LU) concluded trading on Thursday at a closing price of $2.38, with 5.92 million shares of worth about $14.09 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -15.60% during that period and on February 06, 2025 the price saw a gain of about 2.15%. Currently the company’s common shares owned by public are about 838.06M shares, out of which, 837.97M shares are available for trading.
Stock saw a price change of 0.00% in past 5 days and over the past one month there was a price change of 0.85%. Year-to-date (YTD), LU shares are showing a performance of -0.42% which increased to 128.26% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $1.01 but also hit the highest price of $4.15 during that period. The average intraday trading volume for Lufax Holding Ltd ADR shares is 3.09 million. The stock is currently trading -3.53% below its 20-day simple moving average (SMA20), while that difference is down -3.80% for SMA50 and it goes to -5.60% lower than SMA200.
Lufax Holding Ltd ADR (NYSE: LU) currently have 838.06M outstanding shares and institutions hold larger chunk of about 9.90% of that.
The stock has a current market capitalization of $1.99B and its 3Y-monthly beta is at 0.89. It has posted earnings per share of -$0.76 in the same period. It has a debt-to-equity ratio of 0.56. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for LU, volatility over the week remained 4.75% while standing at 5.48% over the month.
Stock’s fiscal year EPS is expected to drop by -385.82% while it is estimated to increase by 139.17% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Jefferies on October 24, 2024 offering a Hold rating for the stock and assigned a target price of $3.20 to it. On August 24, 2023, UBS Downgrade their recommendations, while on June 08, 2023, Bernstein Initiated their ratings for the stock with a price target of $2.50. Stock get an Outperform rating from Macquarie on May 16, 2023.
